Historical Stock Price
ETFs Holding ALT »    ALT Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
12/02/2022 $10.65 $11.33 $10.53 $11.28 1.06M
12/05/2022 $11.39 $11.70 $10.98 $11.06 1.35M
12/06/2022 $10.90 $11.15 $9.97 $10.30 1.08M
12/07/2022 $10.27 $10.44 $10.09 $10.23 572.20K
12/08/2022 $10.35 $10.73 $10.05 $10.35 921.00K
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Co.'s primary product candidate, pemvidutide (proposed INN), is a good laboratory practices-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and non-alcoholic steatohepatitis. In addition, Co. is developing HepTcell, an immunotherapeutic agent designed to achieve a functional cure for chronic hepatitis B.
ALT historical stock prices picture
Altimmune (ALT) has the following price history information. Looking back at ALT historical stock prices for the last five trading days, on December 02, 2022, ALT opened at $10.65, traded as high as $11.33 and as low as $10.53, and closed at $11.28. Trading volume was a total of 1.06M shares. On December 05, 2022, ALT opened at $11.39, traded as high as $11.70 and as low as $10.98, and closed at $11.06. Trading volume was a total of 1.35M shares. On December 06, 2022, ALT opened at $10.90, traded as high as $11.15 and as low as $9.97, and closed at $10.30. Trading volume was a total of 1.08M shares. On December 07, 2022, ALT opened at $10.27, traded as high as $10.44 and as low as $10.09, and closed at $10.23. Trading volume was a total of 572.20K shares. On December 08, 2022, ALT opened at $10.35, traded as high as $10.73 and as low as $10.05, and closed at $10.35. Trading volume was a total of 921.00K shares.

ALT Historical Stock Prices By Date:

ALT historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Altimmune shares, starting with a $10,000 purchase of ALT, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/26/2017
End date: 12/08/2022
Start price/share: $133.20
End price/share: $10.35
Dividends collected/share: $0.00
Total return: -92.23%
Average Annual Total Return: -36.95%
Starting investment: $10,000.00
Ending investment: $776.80
Years: 5.54
Date Close
12/02/2022$11.28
12/05/2022$11.06
12/06/2022$10.30
12/07/2022$10.23
12/08/2022$10.35
ALT is categorized under the Healthcare sector; below are some other companies in the same sector:

ALXA Historical Stock Prices
ALXN Historical Stock Prices
AMAG Historical Stock Prices
AMBI Historical Stock Prices
AMDA Historical Stock Prices
AMED Historical Stock Prices
AMEH Historical Stock Prices
AMF Historical Stock Prices
AMGN Historical Stock Prices
AMN Historical Stock Prices

Also explore: ALT shares outstanding history

Email EnvelopeFree ALT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

ALT Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.